Pharmacogenomic testing is a technology that provides information about our individual metabolism of various psychotropic medications by our liver. It is a quick and painless test that merely requires a DNA sample acquired by a cheek swab. This information can potentially help guide medication choices as it provides information unique to each individual. There is a small but emerging evidence base that supports using this type of testing to help guide medication choices for the treatment of depression.